Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Operating activities
Net income from continuing operations	$ 188.3	$ 462.8	$ 377.5
Loss from discontinued operations, net of income taxes			(193.8)
Adjustments (non-cash items) to reconcile net income to cash provided by operating activities:
Depreciation and amortization	370.9	350.6	397.1
EC antitrust non-cash provision			210.0
Deferred income taxes	(23.9)	(16.0)	3.0
Loss from equity method investments, net of dividends	(0.0)	4.0	31.9
Net change in operating capital:
EC antitrust payment		(203.0)
Receivables and other assets, gross	(414.7)	25.4	(48.4)
Inventories, gross	(34.0)	15.4	(123.9)
Accounts payable and accrued expenses	671.7	35.7	(37.8)
Income taxes	53.5	(29.3)	(19.2)
Other, net	37.1	(4.9)	(5.8)
Net cash provided by operating activities	848.9	640.7	590.6
Investing activities
Expenditures for property, plant and equipment	(343.5)	(483.4)	(560.0)
Proceeds from sale of property, plant and equipment	3.9	7.3	5.2
Acquisition of businesses and interest in affiliates, net of cash acquired			(72.0)
Other			(0.9)
Net cash used in investing activities	(339.6)	(476.1)	(627.7)
Financing activities
Net (decrease) increase in short-term debt	(239.9)	(364.1)	355.4
Increase in long-term debt	1,177.1	243.5	582.2
Repayment of long-term debt	(722.5)
Debt issuance costs		(0.3)	(2.6)
Dividends paid to non-controlling interest	(1.3)	(1.1)	(2.1)
Dividends paid	(54.1)	(217.0)	(214.3)
Common stock options exercised	0.8	0.9	8.2
Capital contribution to Veoneer			(971.8)
Net cash provided by (used in) financing activities	160.1	(338.1)	(245.0)
Effect of exchange rate changes on cash and cash equivalents	64.1	2.4	(61.6)
Increase (decrease) in cash and cash equivalents	733.5	(171.1)	(343.7)
Cash and cash equivalents at beginning of year	444.7	615.8	959.5
Cash and cash equivalents at end of year	$ 1,178.2	$ 444.7	$ 615.8